Nordson Corp (NDSN) Tops Q3 EPS by 8c; Guides In-Line

Nordson Corp (NASDAQ: NDSN) reported Q3 EPS of $1.21, $0.08 better than the analyst estimate of $1.13. Revenue for the quarter came in at $459 million versus the consensus estimate of $449.77 million.

Nordson Corp sees Q4 2014 EPS of $1.07-$1.17, versus the consensus of $1.13. Q4 sales expected to increase 10 to 14 percent over prior year.

“Our team continued to apply our model of innovative products, application expertise and global customer support across our diverse and growing end markets, resulting in organic growth in every segment and geography and all-time quarterly records in sales, operating profit and earnings per share,” said Nordson President and CEO Michael F. Hilton. “Operating margin in the quarter was 25 percent, two percentage points higher than the strong level we delivered in the third quarter a year ago. We also continued our balanced approach to capital deployment during the quarter, investing $36 million for the repurchase of shares and distributing approximately $11 million in dividends during the quarter. Free cash flow in the quarter before dividends was $70 million and our balance sheet has significant capacity for ongoing capital deployment. Shortly after the end of the quarter, we also announced the purchase of Avalon Laboratories, a high performing manufacturer of single use specialty medical tubing. This business is a great strategic addition to our existing range of fluid management solutions for the global medical device market, and we’re pleased to welcome all Avalon employees to Nordson.”

For earnings history and earnings-related data on Nordson Corp (NDSN) click here.

You May Also Be Interested In

• Nanometrics (NANO) Issues Business Update, Reports FY23 Results
• Ball Corporation (BALL) Raises Dividend, Enters 40M Share Buyback, Announces Management Changes
• O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance